Larson Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.92K Hold
500
– – ﹤0.01% 2707
2026
Q2
$15.6K Hold
500
– – ﹤0.01% 2154
2026
Q1
$67.7K Buy
+500
New +$507K ﹤0.01% 1183

Other funds holding LLY

Larson Financial Group's LLY Position: Q3 2026 in Review

Larson Financial Group increased its Eli Lilly (LLY) stake by 32% in Q3 2026, buying an estimated $8.28M and bringing the position to 28,851 shares worth $33.4M. The position accounts for 0.81% of the portfolio, ranked #23.

Larson Financial Group first reported a position in LLY in Q4 2018 and has held it in 32 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Larson Financial Group held 28,851 shares of Eli Lilly worth $33.4M as of Q3 2026.
  • Larson Financial Group bought 7,020 Eli Lilly shares in Q3 2026, an estimated $8.28M.
  • Eli Lilly made up 0.81% of Larson Financial Group's portfolio in Q3 2026, its #23 holding.
  • Larson Financial Group first reported a position in Eli Lilly in Q4 2018 and has held it in 32 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.